Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy
NCT06448702 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-06-13
Summary
Patients with atopic dermatitis (AD) and erythematous skin disease are often treated with topical treatment containing corticosteroids. However, long term use of topical corticosteroid is well known for its potential side-effects such as skin atrophy, hirsutism, dyspigmentation, telangiectasia, and possible skin infection and iatrogenic adrenal insufficiency. Fear about medication side effects would cause lack of adherence to treatment regiments and thus patients would seek for alternative therapies, and a long term safer and affordable treatment modality is required to fill this therapeutic gap.
Enhanced external counter-pulsation (EECP) therapy is a non-invasive method to improve perfusion of vital organs and reduces hypercholesterolemia-induced endothelial damage. It also helped to increase cerebral blood circulation in patients with ischemic stroke and improved neurological recovery.
This study aim to evaluate the efficacy and safety of patients with atopic dermatitis and erythematous/ inflammatory skin diseases to receive EECP therapy combined treatment compared to wet wrap therapy alone.
Conditions
- Atopic Dermatitis
- Inflammatory Skin Disease
Interventions
- PROCEDURE
-
wet wrap therapy
Steps for wet wrap therapy After bath/shower with emollients, pat to remove excess water on body and apply the emollient and/ or steroid cream liberally on the affected area to enhance water absorption and seal in moisture Put wet wrap garment in lukewarm water, squeeze water out of the wet wrap garment, take them out without dribbling of water and then apply on the affected area Put on another layer of dry garments/ warm clothing to cover the wet wrap garments and wear usual clothing as needed Check regularly and keep the wet wrap garments underneath damp with water sprayer or wet towel if necessary Patient is suggested to apply emollients frequently throughout the day to maintain the effect
- DEVICE
-
External compression counter-pulsation (EECP)
External compression counter-pulsation (EECP) is a compression/decompression non-invasive device (Stendo Pulsewave ® V3 CE certificate class IIa) used for lower part of the body (legs, thighs and buttock/hips) to reproduce and stimulate the natural physiological pulsations and the physical shear stress force.
Sponsors & Collaborators
-
The University of Hong Kong
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-03
- Primary Completion
- 2024-12-31
- Completion
- 2025-12-31
More Related Trials
-
Cooling Pillow for Atopic Dermatitis
NCT01132651 ·Status: COMPLETED ·Phase: NA
-
Black Tea Compresses for Facial Eczema and Perioral Dermatitis
NCT02941432 ·Status: COMPLETED ·Phase: NA
-
Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age
NCT03684343 ·Status: TERMINATED ·Phase: NA
-
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
NCT02680405 ·Status: UNKNOWN
-
Scratch Behavior Under Standard of Care
NCT03898427 ·Status: COMPLETED
-
Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
NCT06702293 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Monitoring Of Scratch Via Accelerometry In Children
NCT03873220 ·Status: COMPLETED
-
Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis
NCT06492902 ·Status: COMPLETED ·Phase: NA
-
Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis
NCT02835170 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)
NCT04262791 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers
NCT03301870 ·Status: COMPLETED ·Phase: PHASE1
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1
-
Scratching Validation Study
NCT05137093 ·Status: COMPLETED
-
Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
NCT00196430 ·Status: COMPLETED ·Phase: PHASE3
-
Social Media Follow-up Nursing for Atopic Dermatitis
NCT07142993 ·Status: COMPLETED ·Phase: NA
-
Comparing DCP and DAP for Pemphigus Vulgaris
NCT06846255 ·Status: COMPLETED ·Phase: PHASE4
-
Does Topical Steroid Treatment Impair the Adrenal Function?
NCT00476489 ·Status: UNKNOWN
-
Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis
NCT02823340 ·Status: COMPLETED ·Phase: NA
-
Pre-SunBeam TEWL AUC
NCT04226092 ·Status: COMPLETED ·Phase: NA
-
Topical Corticosteroid App
NCT02921503 ·Status: COMPLETED ·Phase: NA
-
An Explorative Study of Treatment of Contact Dermatitis Due to DiabetesDevices
NCT04909983 ·Status: TERMINATED ·Phase: NA
-
Hydration Sensor for Atopic Dermatitis
NCT03813472 ·Status: COMPLETED
-
Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema
NCT03619161 ·Status: COMPLETED ·Phase: NA
-
Characterization of Chronic Hand Eczema
NCT05026554 ·Status: RECRUITING
-
Etanercept for the Treatment of Chronic Urticaria
NCT01030120 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3